VRDN
Viridian Therapeutics Inc.
$23.11
-$0.52(-2.20%)
59
Overall
60
Value
75
Tech
44
Quality
Market Cap
$1.59B
Volume
763.75K
52W Range
$9.90 - $27.20
Target Price
$39.87
EPS Estimates Overview
| Current Quarter | $-0.82 | Next Quarter | $-0.94 |
| Current Year | $-3.77 | Next Year | $-3.99 |
| QoQ Growth | -14.6% | YoY Growth | -5.8% |
| 3Y EPS CAGR | +22.8% | Target Price | $39.87 |
| Consensus | Buy | Upside | +72.5% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VRDN | $23.11 | -2.2% | 763.75K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Viridian Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW